George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

Share Price Information for Aquis Exchange (AQX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 465.00
Bid: 460.00
Ask: 470.00
Change: -4.00 (-0.85%)
Spread: 10.00 (2.174%)
Open: 465.00
High: 465.00
Low: 458.00
Prev. Close: 469.00
AQX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

22 Sep 2022 07:00

RNS Number : 2239A
Aquis Exchange PLC
22 September 2022
 

22 September 2022

Aquis Exchange PLC

("Aquis", the "Company" or the "Group")

 

Interim results for the six months ended 30 June 2022

Continued revenue growth and investment in the future

 

Aquis Exchange PLC (AQX.L), the exchange services group, is pleased to announce its unaudited results for the six months ended 30 June 2022.

 

Highlights:

 

All three divisions were profitable in the period.

 

·

Net Revenue (1)  increased 21% to £8.3 million (1H21: £6.9 million)

·

EBITDA at £1.4 million (1H21: £1.6 million) following a significant investment in technology and development headcount to drive future growth

·

Pre-tax profit of £0.7 million (1H21: £1.0 million)

·

Cash and cash equivalents at 30 June 2022 of £13.3 million (30 June 2021: £13.9 million)

·

Membership of Aquis Exchange (AQX) grew to 42 (1H21: 39), with a small decline in average monthly usage reflecting more volatile market conditions

·

Market share of all pan-European trading ended the period at 5.20% in 2Q22 (4Q21: 5.35%)

·

12 new admissions to Aquis Stock Exchange (AQSE) completed during 1H22 (1H21: 14))

·

Signature of a new significant multi-year technology licence contract

·

Aquis Matching Pool (AMP) successfully launched following the asset purchase from UBS on 4 April 2022, with average monthly market share of c. 0.5% added to the Group total share

 

Post-period highlights:

 

·

Currently tracking in line with market expectations for the full year

·

Signature of an additional new significant multi-year technology licence contract

 

Alasdair Haynes, Chief Executive Officer of Aquis, commented:

 

"Our revenues have continued to increase, reflecting the strong momentum across the Group. This growth has been driven by increased contributions from the principal business divisions: pan-European secondary trading, technology sales, primary issuers and data revenues. The continued strength of our offering in this division is demonstrated by our finishing with 5.20% of all pan-European secondary trading by the end of 2Q22. We are also particularly encouraged by the number of new significant technology licenses that continue to be signed as this growing division becomes an increasingly material and important part of our business.

 

Aquis also successfully completed the asset purchase of the Aquis Matching Pool from UBS and is now able to offer a full product suite to its customers. We will continue to enhance this area and look forward to offering further product innovation in this space to enable clients to execute the trading strategies they wish.

 

While we anticipate the prevailing economic uncertainty will continue to impact market participants in the short to medium term, we have demonstrated we have the right model, team, technology and vision to deliver shareholder value and look to the future with confidence."

 

 

An overview of the results from Alasdair Haynes, CEO, is available to view on this link:

https://www.brrmedia.co.uk/broadcasts-embed/

 

The Group will be hosting webinars for analysts and retail investors today at 9.30 and 14.30 respectively.

 

If you would like to register for the analyst webinar, please contact aquis@almapr.co.uk . Investors who would like to attend the retail investor webinar can sign up to Investor Meet Company for free and add themselves to the meeting via https://www.investormeetcompany.com/aquis-exchange-plc/register-investor . Investors who have already registered will be automatically invited.

 

 

(1) Net revenue of £8.3m comprises revenues of £7.9m and impairment credit of £0.4m

 

 

 

Enquiries:

 

Aquis Exchange PLC

Alasdair Haynes, CEO

Richard Fisher, CFO

Andrea Lee

 

Tel: +44 (0) 20 3597 6321

VSA Capital Limited (AQSE Corporate Adviser)

Andrew Raca

Pascal Wiese

 

Tel: +44(0)20 3005 5000

Alma PR (Financial PR Adviser)

Caroline Forde

Kieran Breheny

Lily Soares Smith

Pippa Crabtree

 

Tel: +44 (0) 20 3405 0209

Liberum Capital Limited (Nominated Adviser and Joint Broker)

Chris Clarke

Clayton Bush

Edward Thomas

Kane Collings

 

Tel: +44 (0) 20 3100 2000

Canaccord Genuity Limited (Joint Broker)

Emma Gabriel

Patrick Dolaghan

 

Tel: +44 (0) 20 7523 8000

 

 

 

Notes to Editors

About Aquis Exchange PLC

Aquis Exchange PLC and its subsidiaries are an exchange services group, which operate a pan-European cash equities trading businesses (Aquis Exchange), a growth and regulated primary market (Aquis Stock Exchange/AQSE) and develop/license exchange software to third parties (Aquis Technologies).

Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK/Switzerland and in EU27 respectively. Aquis Exchange operates lit and dark order books, covering 16 European markets. For its lit books, Aquis Exchange uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade and does not allow aggressive non-client proprietary trading, which has resulted in lower market impact and signalling risk on Aquis Exchange than other trading venues in Europe.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with different levels of admission criteria. The Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

Aquis Exchange PLC is quoted on the Aquis Stock Exchange and on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to www.aquis.eu.

 

 

 

Chief Executive Officer's Report

 

The six months to 30 June 2022 has been another strong period of growth as we build on the revenues achieved during 2021. In addition, we have made good operational progress in all areas to help drive us towards our long-term goals. The fact that we have achieved all this amidst the continued challenging economic circumstances demonstrates our strong operational resilience and the continued demand for our unique offering.

 

We are very pleased to have acquired and smoothly integrated the Aquis Matching Pool ("AMP") into our suite of product offerings.

 

Operational Review

 

Aquis continued to develop its three divisions throughout the period:

· Aquis Exchange (AQX): its pan-European lit equities market; which now includes its dark pool vehicle AMP;

· Aquis Stock Exchange (AQSE): a primary listings market for small and mid-cap companies;

· Aquis Technologies: a multi-asset class technology licensing service to an international client base

 

The Group's Market Data income stream (generated through the sale of AQX and AQSE data) has continued to grow during the period.

 

This has enabled us to continue our strong growth as synergies are developed and the business potential is harnessed.

 

In the last six months we have accelerated our planned investment in key business areas such as growing our technology development team. This investment both allows us to maintain our internally used Aquis technology set and will help drive the ongoing growth in our technology licencing business.

 

The Exchanges

 

The performance of both Aquis Exchange and Aquis Stock Exchange has progressed well. Exchange revenue increased by £0.5m (10%) from £4.9 million to £5.4 million and the number of Members grew from 39 to 42. Aquis Exchange Members decreased their trading volumes in the period, with an 8% softening in the average monthly usage in terms of chargeable orders (2Q 2022 vs 4Q 2021), reflecting the prevailing volatile market conditions. Despite this reduction the number of monthly subscriptions slightly rose. On average, there were nine Members using the top three (four post new top tier in May) subscription pricing tiers and 24 in the other five tiers, with nine liquidity providers.

 

Issuer revenue increased, reaching £0.4million as the number of admissions on AQSE grew year-on-year.

 

As the business moves forward, we anticipate AQSE and AQX will become increasingly integrated, allowing Members to benefit from the breadth of the Group's offering.

 

Aquis Exchange

Continued revenue growth in the core business despite tough market conditions

 

Aquis Exchange (AQX) is the Group's pan-European lit secondary trading equities market. It comprises the UK MTF (AQXE) and the French MTF serving EU markets (AQEU).

 

Aquis Exchange's market share of all pan-European trading had declined during the end of 2021 and start of 2022 but has averaged in excess of this level during the period since the half year close, reflecting an improved performance and also the inclusion of market share from AMP. Total market share was 5.2% by close of 2Q22 (5.35% 4Q21, 5.77% 2Q21).

 

Aquis Matching Pool: Following the acquisition of the UBS MTF, Aquis is pleased to note the seamless transition of activity with the number of members and levels of trading experienced to date post acquisition consistent on that previously seen, with Management confident that future opportunities to grow from this current base are available through 2022 and beyond.

 

Aquis Exchange currently has an offering in excess of 2,100 stocks and ETFs across 16 European markets with the Czech market added in the period. A significant proportion of Exchange activity is now being executed on AQEU, the Group's French MTF serving EU markets.

 

Available liquidity on the exchange was at 23% in 1H22 (22% in 1H21) and it is expected this will continue to underpin future anticipated growth.

 

The recognition that Aquis Exchange's toxicity is materially lower than its competitors continues to grow amongst investment managers and the wider market. With several market drivers pushing market participants towards lower toxicity, the opportunity for Aquis Exchange to attract a wider membership from across Europe and to facilitate increased trading volumes remains significant.

 

Aquis Stock Exchange (AQSE)

Momentum building despite difficult market conditions

 

AQSE is a modern market for modern businesses, bringing positive disruption and competition to the listed SME sector. As one of the only two existing options for growing SMEs looking to IPO in the UK, Aquis' vision is for AQSE to become the home for quality growth businesses, applying core Aquis values such as transparency and innovation.

 

12 admissions were completed during 1H22 (joint with our principal competitor) compared to 14 during 1H21. All were well supported and there is a very strong pipeline of high growth and 'new economy' businesses in conversation with AQSE regarding IPO.

 

Revenue growth coupled with achieving the targeted cost synergies and savings has significantly reduced the loss generated by AQSE such that the division is currently forecast to at least break even for the financial year 2022.

 

Aquis Technologies

Progress made on a number of projects

 

Aquis licenses its leading exchange-related technology through its Aquis Technologies division. Aquis Technologies creates and licenses technology for high volume, low latency trading platforms, complex connectivity solutions and real-time trade monitoring and surveillance systems for banks, brokers, investment firms and exchanges.

 

Aquis recognises license revenue on completion of project delivery in accordance with IFRS accounting statutes, which can lead to lumpy revenue recognition, period on period. During 1H22 significant progress was made on a number of projects; and Aquis notes one new contract has been signed in the period, and a further one prior to this results announcement however, there were no completed projects during the period, consistent on 1H21. As a result, Aquis Technologies' revenue (net of provision releases) is below that recognised in 2H21, but remains significantly above that recognised in 1H21, increasing to £1.1m (1H21: £0.6m) net of provisions.

 

The successful exchange cloud technology Proof of Concept (PoC) completed in 2021 has continued to demonstrate the quality of the Aquis Technologies offering and has resulted in a number of new exchange platform prospects. The investment we have made in the first half of 2022 has allowed us to further develop our innovative technology which is at the core of Aquis Technologies, and we will be focused on furthering the growth of the Technologies division, developing its products and services to help its clients with the challenges they face and ensuring the high-performance systems continue to be enhanced.

 

Aquis Market Data

 

Aquis generates revenue from the sale of data derived from AQX (AQXE & AQEU) and AQSE to non-Member market participants.

 

Revenue from market data vendors increased significantly by £0.3m, 29%, to £1.4m for the six-month period compared to the 2021 equivalent, with continued growth in both terminal use and non-display licences across the period.

 

Financial Review

 

Net revenue increased 21% to £8.3m (1H21: £6.9m) and the EBITDA profit for the half year was £1.4m, broadly in line with the EBITDA profit of £1.6m generated in 1H21. This EBITDA profit and the profit before tax of £0.7m includes £0.4m of income recognised from an impairment credit per IFRS 9 consistent with the 1H21 impairment credit. The EBITDA has remained broadly consistent as the Group made some controlled increases in costs during both in 1H 2022 and the back end of last year as it continued to invest in personnel and technological resources. The Group will continue to invest in the future to maintain the business' growth momentum.

 

The Group's cash and cash equivalents as at 30 June 2022 were £13.3 million (30 June 2021: £13.9 million).

 

Summary and Outlook

 

Our strategic goal remains to become one of the leading exchange groups through delivering best-in-class trading opportunities, underpinned by our commitment to first class client service, transparency, simplicity and best-in-class technology. To this end, our investment in R&D will help improve the trading experience for clients, as well as improving our market position and providing further growth and value creation for shareholders. We continue to make significant investment in our technology, sales and marketing activities, in particular in cloud technology, to support our long-term growth aspirations across all activities.

 

Alongside this we are working to enhance our software licensing activities and build presence internationally. We are pleased to have made significant progress on a number of material technology contracts post-period end that will support the second half performance and into FY23, as this growing division becomes an increasingly important part of our business.

 

Looking forward, our focus continues to be on executing on our core growth strategy; increasing trading volumes and improving fundraising prospects for small and mid-cap companies. Notwithstanding the macroeconomic uncertainty, current trading is tracking in line with market expectations for the full year.

 

We have built good momentum over the past few years, despite facing numerous challenges along the way. This demonstrated the strength of our team and our offering, and I am excited to see what we can achieve across the next six months.

 

 

Alasdair Haynes

Chief Executive Officer

 

 

AQUIS EXCHANGE PLC

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME FOR THE SIX MONTHS ENDED 30 JUNE 2022

 

6 months ended 30/06/2022

 

Year ended 31/12/2021

 

6 months ended 30/06/2021

 

Note

 

£'000

 

£'000

 

£'000

Income Statement

 

 

 

Revenue

3

 

7,849

17,182

6,687

Impairment credit/(charge)

4

 

425

(972)

178

Administrative expenses

(6,912)

(11,930)

(5,299)

Operating profit

 

1,362

4,280

1,566

Investment income

5

 

4

-

-

Depreciation and amortisation

7,8

 

(632)

(1,032)

(543)

Net finance costs

18

 

(35)

(26)

(15)

Profit before taxation

 

699

3,222

1,008

Income tax

-

-

-

Deferred tax

-

1,089

-

Profit after taxation

 

699

4,311

1,008

Other comprehensive income

 

Items that may be reclassified subsequently toprofit or loss:

Foreign exchange differences on translation of foreign operations, net of tax

17

 

(42)

77

4

Other comprehensive loss for the year

(42)

77

4

Total comprehensive profit for the year

 

657

4,388

1,012

Earnings per share (pence)

6

 

Basic

 

Ordinary shares

3

16

4

Diluted

 

Ordinary shares

2

15

3

 

The consolidated statement of comprehensive income has been prepared on the basis that all operations are continuing operations.

 

 

 

 

 

AQUIS EXCHANGE PLC

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS AT 30 JUNE 2022

 

6 months ended 30/06/2022

 

Year ended 31/12/2021

 

6 months ended 30/06/2021

 

Note

 

£'000

 

£'000

 

£'000

Assets

 

Non-current assets

 

Goodwill

7

 

83

83

83

Intangible assets

7

 

772

754

792

Property, plant and equipment

8

 

4,263

4,146

1,488

Deferred tax asset

10

 

1,292

1,292

204

Trade and other receivables

9

 

4,714

2,745

915

11,124

 

9,020

 

3,482

Current assets

 

Trade and other receivables

9

 

2,786

3,769

3,523

Cash and cash equivalents

13,320

14,046

13,860

16,106

 

17,815

 

17,383

 

Total assets

 

27,230

 

26,835

 

20,085

Liabilities

 

Current liabilities

 

Trade and other payables

11

 

4,453

3,783

2,792

Non-current liabilities

 

Lease liabilities

18

 

3,214

3,423

953

Total liabilities

 

7,667

 

7,206

 

3,745

 

Net assets

 

19,563

 

19,629

 

17,120

 

Equity

 

Called up share capital

12

 

2,751

2,751

2,749

Share premium account

13

 

11,780

11,771

11,738

Other reserves

14

 

1,860

1,118

1,055

Treasury shares

16

 

(3,001)

(1,527)

(561)

Retained earnings

15

 

6,137

5,438

2,135

Foreign currency translation reserve

17

 

36

78

4

Total equity

 

19,563

 

19,629

 

17,120

 

 

 

The notes to the financial statements on pages 6 to 16 form an integral part of these financial statements. The interim financial statements were approved by the board of directors and authorised for issue on 22 September 2022 and are signed on its behalf by:

 

R Fisher

Director

 

A Haynes

Director

 

 

 

 

AQUIS EXCHANGE PLC

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY FOR THE SIX MONTHS ENDED 30 JUNE 2022

 

Note

Share Capital

 

Share Premium

 

Other Reserves

 

 

Treasury Shares

 

Retained Earnings

 

Foreign Currency Translation Reserve

 

Total

 

£'000

 

£'000

 

£'000

 

 

£'000

 

£'000

 

£'000

 

£'000

 

Balance at 1 January 2021

 

2,717

10,892

761

 

(490)

 

1,127

 

1

15,008

 

Profit for the 6-month period ended 30/06/2021

 

 

1,008

1,008

Issue of new shares

32

846

878

Movement in share option reserve

294

294

Movement in treasury shares

 

(71)

(71)

Foreign exchange differences on translation of foreign operations

3

 

3

Balance at 30 June 2021

2,749

11,738

1,055

 

(561)

2,135

4

17,120

Profit for the 6 month period ended

31/12/2021

3,303

3,303

Issue of new shares

2

33

35

Movement in share option reserve

63

63

Movement in Treasury Shares

(966)

(966)

Foreign exchange differences on

translation of foreign operations

74

 

74

Balance at 31 December 2021

2,751

11,771

1,118

(1,527)

5,438

78

19,629

Profit for the 6-month period ended

30/06/2022

699

699

Issue of new shares

12,13

9

9

Movement in share option reserve

14

 

 

 

742

742

Movement in treasury shares

16

 

 

(1,474)

(1,474)

Foreign exchange differences on translation of foreign operations

17

(42)

 

 

(42)

Balance at 30 June 2022

 

2,751

11,780

1,860

 

(3,001)

 

6,137

 

36

19,563

 

AQUIS EXCHANGE PLC

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE SIX MONTHS ENDED 30 JUNE 2022

 

Note

6 months ended 30/06/2022

 

Year ended 31/12/2021

 

6 months ended 30/06/2021

 

£'000

£'000

£'000

Cash flows from operating activities

 

Cash generated/absorbed by operations

19

1,066

3,157

1,215

Tax refunded

-

-

-

Finance expense on lease liabilities

18

35

(26)

(15)

Net cash inflow from operating activities

1,101

 

3,131

 

1,200

 

Investing Activities

 

Recognition of intangible assets

7

(281)

(350)

(154)

Purchase of property, plant and equipment

8

(478)

(320)

(163)

Interest received

5

4

-

-

Net cash used in / generated by investing activities

(755)

 

(670)

 

(388)

 

Financing Activities

 

Proceeds from share issue

12,13

9

913

878

Purchase of treasury shares

16

(1,000)

(1,100)

(71)

Principal portion of lease liability

18

(39)

(573)

(101)

Net cash (used in)/ generated by financing activities

(1,030)

 

(760)

 

777

 

Net increase/(decrease) in cash and cash equivalents

(684)

1,701

1,589

Cash and cash equivalents at the beginning of the period

14,046

12,268

12,268

Effect of exchange rate changes on cash and cash equivalents

(42)

77

3

Cash and cash equivalents at the end of the period

13,320

 

14,046

 

13,860

 

 

AQUIS EXCHANGE PLC

NOTES TO THE FINANCIAL STATEMENTS

 

1. Basis of preparation of half-year report

This condensed consolidated interim financial report for the half-year reporting period beginning 1 January 2022 and ending 30 June 2022 ("interim period") has been prepared in accordance with Accounting Standard IAS 34 Interim Financial Reporting.

The interim report does not include all the notes of the type normally included in an annual financial report. Accordingly, this report is to be read in conjunction with the annual report for the year ended 31 December 2021 and any public announcements made by Aquis Exchange PLC ("Aquis" or the "Company") during the interim reporting period.

The accounting policies adopted are consistent with those of the previous financial year and corresponding interim reporting period.

 

2. Significant changes in the current reporting period

The financial position and performance of the Group was not affected by any specific events and transactions during the six months to 30 June 2022. However, it is worth noting the following:

· On 4 April 2022, the group assumed the business activities of UBS MTF, the non-displayed matching pool. This initiative represented a significant extension of the equities trading services the group offers its clients and complements its existing suite of lit liquidity pools and range of order types.

 

3. Revenue

An analysis of the Group's revenue is as follows:

6 months ended 30/06/2022

 

Year ended 31/12/2021

 

6 months ended 30/06/2021

 

£'000

 

£'000

 

£'000

Exchange Fees

5,387

9,766

4,899

Licence Fees

662

4,405

379

Issuer Fees

424

2,319

340

Data Vendor Fees

1,376

692

1,069

7,849

 

17,182

 

6,687

 

 

 

 

AQUIS EXCHANGE PLC

NOTES TO THE FINANCIAL STATEMENTS (continued)

 

4. Expected credit loss

The expected credit loss on licensing contract assets has been calculated in accordance with IFRS 9: 

 

£'000

 

As at 31/12/2020

 

508

Expected credit loss reversal for the period

(178)

As at 30/06/2021

 

330

Expected credit loss charge for the period

1,150

As at 31/12/2021

 

1,480

Expected credit loss reversal for the period

(425)

As at 30/06/2022

 

1,055

 

5. Investment income

 

6 months ended 30/06/2022

 

Year ended 31/12/2021

 

6 months ended 30/06/2021

 

 

£'000

 

£'000

 

£'000

Interest income on bank deposits

 

4

 

0

 

0

 

6. Earnings per share

6 months ended 30/06/2022

 

Year ended 31/12/2021

 

6 months ended 30/06/2021

 

Number of Shares ('000)

 

Weighted average number of ordinary shares for basic earnings per share

27,509

27,340

27,197

Weighted average number of ordinary shares for diluted earnings per share

28,431

28,457

28,638

Earnings (£'000)

 

Profit for the period from continued operations

699

4,311

1,008

Basic and diluted earnings per share (pence)

 

Basic earnings per ordinary share

3

16

4

Diluted earnings per ordinary share

2

15

3

 

 

 

 

AQUIS EXCHANGE PLC

NOTES TO THE FINANCIAL STATEMENTS (continued)

 

7. Intangible assets

Group Developed Trading Platforms

 

Other Intangibles

 

 

 

Goodwill

 

 

 

 

£'000

£'000

 

£'000

 

Cost

 

 

 

 

As at 31/12/2020

2,698

-

83

 

Additions- internally generated

154

-

-

 

As at 30/06/2021

2,852

-

83

 

Additions - internally generated

159

37

0

 

As at 31/12/2021

3,011

37

83

 

Additions

282

-

-

 

As at 30/06/2022

3,293

37

83

 

 

 

Accumulated amortisation and impairment

 

 

 

 

 

As at 31/12/2020

1,782

-

-

 

Charge for the period

278

-

-

 

As at 30/06/2021

2,060

-

-

Charge for the period

226

-

-

 

As at 31/12/2021

2,286

8

 

 

Charge for the period

258

6

-

 

As at 30/06/2022

2,544

14

-

 

 

 

Carrying amount

 

 

 

 

As at 31/12/2020

916

-

83

 

As at 30/06/2021

792

-

83

 

As at 31/12/2021

725

29

83

 

As at 30/06/2022

749

23

83

 

 

 

 

 

 

 

 

AQUIS EXCHANGE PLC

NOTES TO THE FINANCIAL STATEMENTS (continued)

 

8. Property, plant and equipment

Fixtures, fittings and equipment

 

Computer Equipment

 

Right of Use Asset

 

Total

 

£'000

 

£'000

 

£'000

 

£'000

Cost

 

As at 31/12/2020

252

2,211

1,444

3,907

Additions & disposals

-

163

-

163

As at 30/06/2021

252

2,374

1,444

4,070

Additions & disposals

72

15

2,795

2,882

As at 31/12/2021

324

2,389

4,329

6,952

Additions & disposals

168

312

-

480

As at 30/06/2022

492

 

2,701

 

4,239

 

7,432

 

Accumulated depreciation and impairment

 

As at 31/12/2020

178

1,804

346

2,328

Charge for the period

25

142

87

254

As at 30/06/2021

203

1,946

433

2,582

Charge for the period

27

129

68

224

As at 31/12/2021

230

2,075

501

2,806

Charge for the period

38

152

173

363

As at 30/06/2022

268

 

2,227

 

674

 

3,169

 

Carrying amount

 

As at 31/12/2020

74

407

1,098

1,579

As at 30/06/2021

49

428

1,011

1,488

As at 31/12/2021

94

314

3,738

4,146

As at 30/06/2022

224

 

474

 

3,565

 

4,263

 

 

 

 

 

 

AQUIS EXCHANGE PLC

NOTES TO THE FINANCIAL STATEMENTS (continued)

 

9. Trade and other receivables

Current

 

As at 30/06/2022

As at 31/12/2021

As at 30/06/2021

 

£'000

 

£'000

 

£'000

Trade receivables net of impairment

2,096

2,997

2,918

Prepayments

683

433

598

Other receivables

7

339

7

2,786

 

3,769

 

3,523

 

Non-Current

 

As at 30/06/2022

As at 31/12/2021

As at 30/06/2021

 

£'000

 

£'000

 

£'000

Trade receivables net of impairment

4,079

2,416

690

Other receivables

635

329

225

4,714

 

2,745

 

915

 

Trade receivables are stated net of any credit impairment provision as set out previously in Note 3 in accordance with IFRS 9, as illustrated below:

 

As at 30/06/2022

As at 31/12/2021

As at 30/06/2021

 

 

£'000

 

£'000

 

£'000

Gross trade receivables

7,311

6,940

3,957

Expected credit losses on contract assets

(1,055)

(1,527)

(349)

Provisions against trade receivables

(81)

 

-

-

Trade receivables net of impairment

6,175

 

5,413

 

3,608

 

Impairment includes the expected credit loss on licencing contract assets stated in Note 4.

AQUIS EXCHANGE PLC

NOTES TO THE FINANCIAL STATEMENTS (continued)

 

10. Deferred tax asset

A deferred tax asset was recognised in the year ended 31 December 2020, due to the Group becoming profitable for the first time. The Group is expected to continue to be profitable in future years, with the value of the deferred tax asset to be reassessed annually at year end. 

As at 30/06/2022

As at 31/12/2021

As at 30/06/2021

 

£'000

 

£'000

 

£'000

Deferred tax asset

1,292

1,292

204

 

11. Trade and other payables

As at 30/06/2022

As at 31/12/2021

As at 30/06/2021

 

 

Trade payables

499

171

264

Accruals

1,048

1,811

1,028

Social security and other taxation

782

507

190

Deferred revenue

1,604

883

935

Short term lease liabilities

435

208

-

Other payables

 

85

203

375

4,453

 

3,783

 

2,792

 

12. Called up share capital

 

As at 30/06/2022

As at 31/12/2021

As at 30/06/2021

 

£'000

 

£'000

 

£'000

Ordinary share capital

 

Issued and fully paid

 

27,149,559 Ordinary shares of 10p each

2,751

2,717

2,717

Issue of new shares following exercise of 323,267 EMI share options

-

-

32

Issue of new shares following exercise of 20,137 EMI share options

-

34

-

Ordinary share capital

2,751

 

2,751

 

2,749

 

 

 

AQUIS EXCHANGE PLC

NOTES TO THE FINANCIAL STATEMENTS (continued)

 

13. Share premium account

As at 30/06/2022

As at 31/12/2021

As at 30/06/2021

 

£'000

 

£'000

 

£'000

Share premium

At beginning of year

11,771

10,892

10,892

Issue of new shares following exercise of 323,267 EMI share options

-

-

846

Issue of new shares following exercise of 20,137 EMI share options

-

879

-

Issue of new shares following exercise of 2,666 EMI share options

9

-

-

Share premium

11,780

 

11,771

 

11,738

 

14. Other Reserves

£'000

 

As at 31/12/2020

761

Share-based payment expense for the 6-month period ended 30/06/2021

294

As at 31/06/2021

1,055

Share-based payment expense for the 6-month period ended 31/12/2021

63

As at 31/12/2021

1,118

Share-based payment expense for the 6-month period ended 30/06/2022

742

As at 30/06/2022

1,860

 

The reserves relating to share-based payments reflects the estimated value of the approved employee share option schemes, which include the EMI, CSOP, PPO and Restricted Share options. The valuation of the options granted is estimated using a US binomial or Black Scholes model. Also included in the share-based payment reserve are the treasury shares purchased by the Trust under the Share Incentive Plan.

 

 

 

 

 

 

 

 

AQUIS EXCHANGE PLC

NOTES TO THE FINANCIAL STATEMENTS (continued)

 

15. Retained earnings

£'000

 

As at 31/12/2020

1,127

Profit for the 6-month period ended 30/06/2021

1,009

As at 31/06/2021

2,136

Profit for the 6-month period ended 30/12/2021

3,302

As at 31/12/2021

5,438

Profit for the 6-month period ended 30/06/2022

699

As at 30/06/2022

6,137

16. Treasury shares

Treasury shares are purchased by a Trust under the Employee Share Plans. The Trust is consolidated within the Group financial statements and the value of the shares held at the balance sheet date is shown below.

As at 30/06/2022

As at 31/12/2021

As at 30/06/2021

 

£'000

 

£'000

 

£'000

Share premium

At beginning of period

1,527

561

490

Purchase of treasury shares

1,474

966

71

Treasury shares at close of period

3,001

 

1,527

 

561

 

17. Foreign currency translation reserve

The translation of the European subsidiary into the functional currency of the group results in foreign exchange differences that have been recognised in Other Comprehensive Income ('OCI') for the group which have been accumulated in a separate component of equity as illustrated below.

6 months ended 30/06/2022

 

Year ended 31/12/2021

 

6 months ended 30/06/2021

 

£'000

 

£'000

 

£'000

At the beginning of the year/period

78

4

1

Foreign exchange differences on translation of foreign operations recognised in OCI

(42)

74

3

At the end of the year/period

36

 

78

 

4

 

 

 

 

AQUIS EXCHANGE PLC

NOTES TO THE FINANCIAL STATEMENTS (continued)

 

18. IFRS 16 Leases

 

 

The impact on the Groups assets and liabilities, and the related effects on profit and loss, of the Groups leasing activities

(the Group as a lessee) are detailed below.

Right of Use Asset

 

Property

£'000

Carrying amount at 1 January 2021

1,098

Depreciation for the period

(87)

Carrying amount at 30 June 2021

1,011

Depreciation for the period

(67)

Additions

3,758

Disposals

(964)

Carrying amount at 31 December 2021

3,738

Depreciation for the period

(173)

Carrying amount at 30 June 2022

3,565

Of which are:

Current

341

Non-current

3,224

3,565

 

Rent deposit asset

 

 

 

Rent deposit asset

£'000

Carrying amount at 1 January 2021

229

Finance income on rent deposit asset for the period

3

Carrying amount at 30 June 2021

232

Finance income on rent deposit asset for the period

6

Additions

374

Carrying amount at 31 December 2021

612

Finance income on rent deposit asset for the period

22

Carrying amount at 30 June 2022

634

Of which are:

Current

284

Non-current

350

634

 

AQUIS EXCHANGE PLC

NOTES TO THE FINANCIAL STATEMENTS (continued)

 

Lease liability

 

Lease liability

£'000

Carrying amount at 1 January 2021

1,190

Finance expense on lease liability for the period

18

Lease payments made during the period

(116)

Carrying amount at 30 June 2021

1,092

Finance expense on lease liability for the period

17

Lease payments made during the period

(114)

Reduction in assumed lease liability

(926)

Additions

3,563

Carrying amount at 31 December 2021

3,631

Finance expense on lease liability for the period

57

Lease payments made during the period

(39)

Carrying amount at 30 June 2022

3,649

Of which are:

Current

435

Non-current

3,214

 

 

Net finance expense on leases

 

 

6 months ended 30/06/2022

Year ended 31/12/2021

6 months ended 30/06/2021

 

£'000

£'000

£'000

Finance expense on lease liability

57

35

18

Finance income on rent deposit asset

(22)

(9)

(3)

Net finance expense relating to leases

35

26

15

 

 

The finance income and finance expense arising from the Groups leasing activities as a lessee have been shown net where applicable

 as is permitted by IAS 32 where criteria for offsetting have been met.

Amounts recognised in profit and loss

 

 

6 months ended 30/06/2022

Year ended 31/12/2021

6 months ended 30/06/2021

 

£'000

£'000

£'000

Depreciation expense on right-of-use assets

(173)

(149)

(87)

Finance expense on lease liability

(57)

(35)

(18)

Finance income on rent deposit asset

22

9

3

Net impact of leases on profit or loss

(208)

(175)

(102)

 

 

 

AQUIS EXCHANGE PLC

NOTES TO THE FINANCIAL STATEMENTS (continued)

The total cash outflow for leases amounted to £39k in the 6 months to 30th June 2022.

 

19. Cash generated from operations

6 months ended 30/06/2022

 

Year ended 31/12/2021

 

6 months ended 30/06/2021

 

 

£'000

 

£'000

 

£'000

 

Profit after tax

699

4,311

1,008

Adjustments for:

 

Deferred tax

-

(1,089)

-

Investment revenue

(4)

-

-

Amortisation and impairment of intangible assets

264

506

278

Depreciation of property, plant and equipment

369

519

254

Equity settled share-based payment expense

289

572

294

Other (gains)/losses

(26)

325

39

Movement in working capital:

 

Increase in trade and other receivables

(986)

(2,750)

(674)

Increase in trade and other payables

461

764

16

Cash generated/ (absorbed) by operations

1,066

 

3,158

 

1,215

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR SEWFUFEESEFU
Date   Source Headline
18th Apr 20242:30 pmRNSResult of AGM and Confirmation of Board Change
22nd Mar 20247:00 amRNSPublication of Annual Report and Notice of AGM
21st Mar 20247:00 amRNSResults for the year ended 31 December 2023
13th Mar 20247:00 amRNSContract with the Central Bank of Colombia
12th Mar 20247:00 amRNSAquis to Establish New Real Assets Market Segment
26th Feb 20247:00 amRNSAquis launches conditional order functionality
23rd Feb 20247:00 amRNSNotice of Results and Investor Presentation
25th Jan 20247:00 amRNSTrading Update and Notice of Results
23rd Jan 20243:15 pmRNSExercise of Share Options and Total Voting Rights
21st Dec 20231:15 pmRNSDirector/PDMR Notification
29th Nov 20237:00 amRNSAQSE becomes first cloud-based RIE
24th Nov 202312:00 pmRNSDirector/PDMR Notification
2nd Nov 20237:00 amRNSHolding(s) in Company
31st Oct 202311:55 amRNSBoard Change
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 202312:39 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSInterim Results
12th Sep 20237:00 amRNSAquis Markets - Change to Proprietary Trading Rule
7th Sep 20237:00 amRNSNotice of Results and Investor Presentation
6th Sep 20237:00 amRNSAppointment of Nominated Adviser and Joint Broker
7th Aug 20232:15 pmRNSAcquisition of Minority Interest
28th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSAquis launches Dark to Lit Sweep
27th Apr 20237:00 amRNSDirector/PDMR Notification and Issue of Options
25th Apr 20232:18 pmRNSResult of AGM
14th Apr 20237:00 amRNSPublication of Annual Report & Notice of AGM
6th Apr 20231:05 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSDirector/PDMR Shareholding
3rd Apr 202310:55 amRNSDirector/PDMR Shareholding
3rd Apr 20237:01 amRNSDirector/PDMR Shareholdings
3rd Apr 20237:00 amRNSAquis Launches The World’s First 24x7 Exchange
30th Mar 20237:00 amRNSFinal Results
22nd Feb 20237:00 amRNSNotice of Results and Investor Presentation
2nd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
2nd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
26th Jan 20237:00 amRNSTrading Update and Notice of Results
5th Jan 20237:00 amRNSDirectorate Change
12th Dec 20227:00 amRNSIG Expands UK Trading Offering With AQSE Stocks
24th Nov 20229:13 amRNSDirector/PDMR Notification
23rd Nov 20224:09 pmRNSDirector/PDMR Notification
2nd Nov 20227:00 amRNSNotice of Capital Markets Day
27th Sep 20227:00 amRNSNotice of Capital Markets Day
22nd Sep 20227:00 amRNSInterim Results
5th Sep 202212:00 pmRNSLaunch of new EU dark pool, Aquis Matching Pool
23rd Aug 20227:00 amRNSNotice of Results
6th Jul 202212:00 pmRNSAPEX stocks now trading on Hargreaves Lansdown
30th Jun 202212:49 pmRNSDirector/PDMR Notification and Issue of Options
23rd Jun 20227:00 amRNSDirector/PDMR Shareholding
22nd Jun 202212:30 pmRNSExercise of Share Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.